Resources

Download Now: Curapath-Knauer Application Note

Form

Fill Out The Form To Begin Your Download

Captura de pantalla 2022-11-23 120532

Lipid nanoparticles (LNPs) offer significant advantages as a delivery system for a nucleic-acids therapeutics. In addition to functional advantages, such as biocompatibility, biodegradability and high entrapment efficency, LNPs can be manufactured rapidly, reproducibly, and with high scalability. At Curapath, we optimize LNP formulation during pre-clinical research and development in order to determine the optimal conditions for the encapsulation of nucleic acids.

Resources

CDMO Brochure

Optimize Your Formulation
Processes and Fill & Finish
Requests with Robust Precision
Lipid and Polymer Services 

pSar White Paper

Polysarcosine (pSar), a safer, more effective alternative to poly-ethylene glycol (PEG)

Curapath-Knauer Services Flyer

LNP Formulation and Analytical Services

Polymeric Nanoparticles Case Study

Development of a Highly Efficient, Biodegradable, Polymeric, Non-viral Vector (NVV) Platform for Nucleic Acid Delivery

Curapath-Knauer Application Note

Development and Optimization of LNP Formulations using the NanoScaler

pSar-VitE General Excipient Case Study

Development of PEG-free Excipients for
Drug Delivery
Lipid-Nanopeptide_0
Support for Your Therapeutic Program

Contact a Chemist Today

Contact Us, and we can discuss your specific therapeutic program and how Curapath can help build the right solution to advance your unique drug.